Ondřej Skořepa and Celeste Abreu at the 48th FEBS Congress

Postdoctoral researcher Ondřej Skořepa and PhD student Celeste Abreu from our laboratory participated in the 48th FEBS Congress, held in Milan, Italy, from 29 June to 3 July 2024. This prestigious event, hosted by the Italian Society of Biochemistry and Molecular Biology (SIB), brought together scientists from around the world to discuss the latest advancements in biochemistry and molecular biology under the theme “Mining Biochemistry for Human Health and Well-being.”

Celeste Abreu presented her research on “Optimizing the production of recombinant human Galectin-1: a general protocol for maintaining stability and lectin activity in the long run”, focusing on the functional and structural characterisation of Galectin-1, a protein involved in various human pathologies and relevant to immunotherapy. Ondřej Skořepa contributed with his study on “Elucidation of the structure of NKp30 receptor oligomers”, which examines how NKp30 glycosylation and oligomerisation influence NK cell activity, with potential implications for designing novel anti-cancer strategies.

Abreu C., Kozák J., Hofbauerová K., Kopecký V. Jr., Vaněk O.: Optimizing the production of recombinant human Galectin-1: a general protocol for maintaining stability and lectin activity in the long run. 48th FEBS Congress, 29.6.-3.7. 2024, Milan, Italy, FEBS Open Bio 14 Suppl 2, 450. DOI: 10.1002/2211-5463.13837

Skořepa O., Pazicky S., Kalousková B., Bláha J., Abreu C., Ječmen T., Rosůlek M., Fish A., Sedivy A., Harlos K., Dohnálek J., Vaněk O.: Elucidation of the structure of NKp30 receptor oligomers. 48th FEBS Congress, 29.6.-3.7. 2024, Milan, Italy, FEBS Open Bio 14 Suppl 2, 378. DOI: 10.1002/2211-5463.13837